Leaflet IRBEC 150mg tablets
Indicated for: hypertension
Route of administration: oral
Substance: irbesartan (angiotensin II receptor blocker)
ATC: C09CA04 (Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain)
Do not use this medicine during pregnancy.
May lower blood pressure and increase the risk of falls.
This medicine may have important interactions with other medicines.
Periodic laboratory tests may be required during treatment.
This medicine may change blood electrolyte levels.
Irbesartan is a medication used to treat high blood pressure and diabetic nephropathy in patients with type 2 diabetes. It belongs to the class of angiotensin II receptor antagonists and works by relaxing blood vessels, thereby lowering blood pressure.
The medication is taken orally, usually once daily, as directed by a doctor.
Side effects may include dizziness, fatigue, nausea, or increased potassium levels in the blood. In rare cases, severe allergic reactions or kidney dysfunction may occur.
Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.
General data about IRBEC 150mg
- Substance: irbesartan
- Date of last drug list: 01-07-2013
- Commercial code: W54086001
- Concentration: 150mg
- Pharmaceutical form: tablets
- Quantity: 14
- Product type: generic
- Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Pharmaceutical forms available for irbesartan
Concentrations available for irbesartan
- 150mg
- 300mg
- 7.5mg
- 75mg